Sign in

Steven Chaouki

Director at MAIA
Board

About Steven Chaouki

Steven M. Chaouki, age 52, serves as an independent Class I director at MAIA Biotechnology. He is President, U.S. Markets & Consumer Interactive at TransUnion and previously EVP, Financial Services; earlier roles included HSBC card/retail services and auto finance. He holds an MBA from the University of Chicago Booth School of Business and a bachelor’s degree from Boston University. He has served on MAIA’s board since at least 2021 and is designated as an audit committee financial expert .

Past Roles

OrganizationRoleTenureCommittees/Impact
TransUnionPresident, U.S. Markets & Consumer Interactive; previously EVP, Financial ServicesNot disclosed (in role since at least 2008 per prior proxy language)Oversees U.S. Markets and Consumer Interactive businesses; deep financial services domain expertise .
HSBCRoles in card/retail services and auto financeNot disclosedFinancial operations and consumer credit experience .

External Roles

OrganizationRolePublic Company DirectorshipNotes
TransUnionSenior executive (President, U.S. Markets & Consumer Interactive)Not disclosed as a directorExecutive role only; no MAIA-related transactions disclosed .

Board Governance

  • Board classification: Class I; term expires at the 2026 annual meeting; all directors except the CEO are independent; lead independent director is Stan V. Smith .
  • Committee memberships: Audit Committee member (chair: Louie Ngar Yee); Compensation Committee (Smith-Chair, Luput, Guerrero) and Nominating & Corporate Governance Committee (Louie-Chair, Luput, Smith) – Chaouki is listed only on Audit .
  • Attendance: Board held 4 meetings in 2024; all directors attended all Board meetings. Audit Committee held 4 meetings; all members attended all meetings .
  • Independence: Board determined all directors other than CEO Vlad Vitoc are independent (includes Chaouki) .

Fixed Compensation

ComponentPolicy/AmountTiming/VestingNotes
Director annual retainer (equity-only)$60,000 in stock options per year (11/15/2022–1/31/2025); increased to $100,000 in stock options per year starting 2/1/2025Granted quarterly in equal installments; options vest/distribute quarterlyNo cash fees; options valued at period-end closing price .
Committee chair/member equityAudit Chair: $15,000 options per year (pre-2/1/2025), then $7,500 options per year (from 2/1/2025); Comp and Nominating members: $5,000 options per year (from 2/1/2025)Quarterly grants and vestingChaouki is not a chair; he is an Audit member .
2024 actual board option grant (Chaouki)32,378 optionsDuring 2024Per non-employee director compensation table; no cash paid .

Performance Compensation

FeatureDetailsNotes
Performance metrics tied to director payNone disclosed for non-employee directorsDirector compensation is equity-only options with quarterly vesting; no specific performance metrics described .
Plan provisions (general)2021 Equity Incentive Plan allows performance shares/units, SARs, RSUs, optionsPlan permits performance-based awards, but director policy uses options; change-in-control actions at committee discretion .

Other Directorships & Interlocks

EntityTypeRelationship to MAIAPotential Interlock/Conflict
TransUnionPublic company; Chaouki is a senior executiveNo MAIA-related transactions disclosedNo related-party transactions involving Chaouki disclosed; independence affirmed .

Expertise & Qualifications

  • Financial and audit expertise: Designated audit committee financial expert; deep experience in financial services and consumer credit data .
  • Education: MBA, University of Chicago Booth; BA, Boston University .
  • Board qualifications: Management and financial expertise; independence .

Equity Ownership

HolderShares Owned (Common)Options/Warrants Exercisable Within 60 DaysTotal Beneficial Ownership% of Class
Steven Chaouki111,024151,578262,602Less than 1% .
  • Pledging/Hedging: Company insider trading policy prohibits hedging and pledging without pre-clearance; as of 12/31/2024, none of the directors or executives had pledged MAIA shares .

Insider Trades (Form 4 – Recent)

Filing DateTransaction DateTypeSecurityQuantityPricePost-Transaction Securities OwnedSEC Link
2025-10-062025-10-02Award (A)Stock Options20,946$1.8020,946https://www.sec.gov/Archives/edgar/data/1878313/000187831325000027/0001878313-25-000027-index.htm
2025-07-022025-06-30Award (A)Stock Options20,865$1.8020,865https://www.sec.gov/Archives/edgar/data/1878313/000112760225018656/0001127602-25-018656-index.htm
  • 2024 director purchases in company private placements (non-compensatory; issued under 2021 Plan as Unrestricted Stock Awards and Awards of Options at same terms as third-party investors): 34,641 shares ($~40,530) with 34,641 warrants (exercise $1.30); 22,133 shares ($~50,000) with 22,133 warrants (exercise $2.51) .

Governance Assessment

  • Strengths: Independent director; audit committee financial expert; perfect Board and Audit Committee attendance in 2024; engaged through equity participation in private placements alongside outside investors (alignment signal) .
  • Compensation: Equity-only option compensation (no cash), quarterly vesting; policy increased to $100k options from Feb 2025, supporting at-risk, equity-aligned pay; no performance metrics disclosed for directors .
  • Conflicts/Related Parties: No related-party transactions involving Chaouki disclosed; insider trading/hedging/pledging restrictions in place and no pledging as of 12/31/2024 .
  • Structure: Board is staggered; lead independent director in place; strong audit oversight with financial experts; potential investor dilution risk addressed elsewhere in proxy through authorized share increase rationale (not board-specific) .

RED FLAGS

  • None disclosed specific to Chaouki: no legal proceedings, no related-party transactions, no pledging, and full meeting attendance .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%